肺状细胞癌中lncRNA TPT1-AS1的表达及其预后值
Lixin Yu1, Zhenkui Zhang2, Zhijian Wang2
1Department of Thoracic Surgery, Beijing Chao-Yang Hospital, Capital Medical University, 5 Jingyuan Road, Shijingshan District, Beijing, 100020, China. lixinyu9632@163.com.
Discover oncology
|November 11, 2024
概括
长非编码RNATPT1-AS1,当过度表达时,可以通过向miR-4726-5p来抑制肺平细胞癌 (LUSC) 的进展. TPT1-AS1作为LUSC患者的潜在预后标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 肺状细胞癌 (LUSC) 的预后不佳,需要新的预后标志物.
- 长非编码RNAs (lncRNAs) 的异常表达与各种癌症有关.
- 一种lncRNA的TPT1-AS1在多种癌症类型中表达变化.
研究的目的:
- 为了调查TPT1-AS1在LUSC中的预后意义.
- 在LUSC.中探索TPT1-AS1和miR-4726-5p之间的关系.
- 评估TPT1-AS1在LUSC进展中的功能作用.
主要方法:
- 在使用RT-qPCR的115名LUSC患者中,对TPT1-AS1和miR-4726-5p的表达分析.
- TPT1-AS1表达和临床病理特征之间的相关性分析.
- 双露西法酶记者测定证实了TPT1-AS1针对miR-4726-5p.p.的向.
- 细胞增殖,迁移和入侵测定 (CCK-8,Transwell) 来评估功能影响.
主要成果:
- 在LUSC组织中,TPT1-AS1表达的下调,而miR-4726-5p的上调.
- 较低的TPT1-AS1表达与较短的整体存活率相关,并将TPT1-AS1确定为独立的预后因素.
- TPT1-AS1直接准miR-4726-5p,在瘤中观察到它们的表达水平之间存在逆相关性.
- 过度表达TPT1-AS1抑制了LUSC细胞的增殖,迁移和入侵.
结论:
- 在LUSC中,TPT1-AS1通过准miR-4726-5p作为瘤抑制剂.
- TPT1-AS1有可能成为LUSC.的预后生物标志物.
- 调节TPT1-AS1表达可能为LUSC.提供治疗策略.
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K


